Result Summary for 101468/127
| Protocol ID: | 101468/127 |
| Clinical Study ID: | 101468/127 |
| Official Title: | A Double-blind, Randomised, Bromocriptine-controlled Study of Ropinirole at a Flexible Oral Dose of 0.25-3.0mg Three Times Daily for 4 Months in the Treatment of Parkinsonian Patients (Hoehn and Yahr Stage II-IV) Not Optimally Controlled on L-dopa (DCI). |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | ropinirole |
| Trade/Product Name: | requip;requip |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
